) was a big mover last session, as the company saw its shares
rise by almost 6% on the day. The move came on solid volume too
with far more shares changing hands than in a normal session.
This continues the recent uptrend of the company as the stock has
now gained almost 35% since Nov 12.
This biotechnology company has seen a mixed track record when it
comes to estimate revisions of one increase and one decrease over
the past 7 days and the Zacks Consensus Estimate has moved higher
over the same time frame. The recent price action is encouraging
though, so make sure to keep a close watch on this firm in the
Athersys currently has a Zacks Rank #3 (Hold) while its
Some better-ranked stocks in the same sector include
Cytori Therapeutics, Inc.
). While Heska Corporation and Actelion hold a Zacks Rank #1
(Strong Buy), Cytori Therapeutics carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report >>
ACTELION LTD (ALIOF): Get Free Report
ATHERSYS INC (ATHX): Free Stock Analysis
CYTORI THERAPEU (CYTX): Free Stock Analysis
HESKA CORP (HSKA): Free Stock Analysis Report
To read this article on Zacks.com click here.